Journal article

How Subclonal Modeling Is Changing the Metastatic Paradigm

Geoff Macintyre, Peter Van Loo, Niall M Corcoran, David C Wedge, Florian Markowetz, Christopher M Hovens

Clinical Cancer Research | AMER ASSOC CANCER RESEARCH | Published : 2017


Awarded by NHMRC

Awarded by Cancer Research UK

Awarded by UK Medical Research Council

Awarded by Wellcome Trust

Awarded by CRUK core grant

Awarded by The Francis Crick Institute

Funding Acknowledgements

This work was supported by: a Federal grant for the Australian Prostate Cancer Research Centres and by NHMRC grants 1047581 and 1104010 (to C.M. Hovens and N.M. Corcoran), the Cancer Research UK (grants A15973 and A15601d; to G. Macintyre), the Francis Crick Institute, which receives its core funding from Cancer Research UK (FC001202), the UK Medical Research Council (FC001202), and the Wellcome Trust (FC001202; to P. Van Loo), The University of Cambridge, Cancer Research UK, Hutchinson Whampoa Limited, CRUK core grant C14303/A17197 (CRUK CI Institute core grant; to F. Markowetz and G. Macintyre), and A19274 (F. Markowetz lab grant). D.C. Wedge is funded by the Li Ka Shing foundation.